UnitedHealth Group’s (UNH) Overweight Rating Reiterated at Cantor Fitzgerald

UnitedHealth Group (NYSE:UNH)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a report issued on Friday,Benzinga reports. They presently have a $700.00 price target on the healthcare conglomerate’s stock. Cantor Fitzgerald’s target price points to a potential upside of 36.30% from the stock’s previous close.

Several other research analysts have also weighed in on UNH. Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Truist Financial dropped their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and three have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $629.74.

UnitedHealth Group Stock Up 0.6 %

UNH stock opened at $513.58 on Friday. UnitedHealth Group has a one year low of $436.38 and a one year high of $630.73. The company has a 50 day moving average price of $553.38 and a two-hundred day moving average price of $562.98. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market capitalization of $472.64 billion, a P/E ratio of 33.50, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the company earned $5.83 EPS. As a group, sell-side analysts expect that UnitedHealth Group will post 27.6 EPS for the current year.

Hedge Funds Weigh In On UnitedHealth Group

Large investors have recently modified their holdings of the stock. Aspire Private Capital LLC grew its position in shares of UnitedHealth Group by 3.2% in the 4th quarter. Aspire Private Capital LLC now owns 1,942 shares of the healthcare conglomerate’s stock worth $982,000 after acquiring an additional 61 shares in the last quarter. Commons Capital LLC increased its stake in UnitedHealth Group by 2.0% during the fourth quarter. Commons Capital LLC now owns 3,451 shares of the healthcare conglomerate’s stock valued at $1,746,000 after purchasing an additional 68 shares during the last quarter. Fort Washington Investment Advisors Inc. OH boosted its holdings in shares of UnitedHealth Group by 2.3% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 528,638 shares of the healthcare conglomerate’s stock valued at $267,417,000 after buying an additional 11,812 shares during the period. JBGlobal.com LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $294,000. Finally, Enclave Advisors LLC lifted its holdings in shares of UnitedHealth Group by 2.5% in the 4th quarter. Enclave Advisors LLC now owns 3,227 shares of the healthcare conglomerate’s stock worth $1,632,000 after purchasing an additional 79 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.